MBI proves more cost effective than other imaging modalities in Breast Cancer diagnosis as a secondary screening tool to Mammography in women with Dense Breasts – Mayo Clinic
Molecular Breast Imaging Solutions was established with the belief that everyone deserves access to improved health outcomes.
We have partnered with Evo Worldwide in order to make the GE Discovery NM750b Molecular Breast Imaging System available to Medical Professionals and their patients throughout Australia and New Zealand.
MBIS believes passionately in this technologically-advanced and cost effective imaging modality and its potential for
improved breast cancer diagnosis.
MBI is a safe, reliable and comfortable solution for Breast Cancer detection in women with Dense Breast Tissue who are at higher risk for developing Breast Cancer
The addition of MBI to screening mammography leads to the detection of almost 4 times more cancers than mammography alone
– Mayo Clinic
Copyright 2017 Molecular Breast Imaging Solutions.
Web Design by Alloy Media.
MBI leads to a lower rate of negative (unnecessary)biopsies compared to other supplemental screening techniques
– Mayo Clinic
The Discovery NM750b boasts High Sensitivity and Specificity using Direct Conversion Technology with dual CZT detectors designed to acquire images analogous to Mammography.